Provided by Tiger Trade Technology Pte. Ltd.

BridgeBio Pharma, Inc.

76.59
-0.0100-0.01%
Post-market: 76.590.00000.00%19:41 EDT
Volume:2.06M
Turnover:157.22M
Market Cap:15.00B
PE:-21.46
High:77.24
Open:76.20
Low:75.02
Close:76.60
52wk High:93.42
52wk Low:48.78
Shares:195.81M
Float Shares:167.00M
Volume Ratio:1.42
T/O Rate:1.24%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-3.5686
EPS(LYR):-3.7850
ROE:-1789.67%
ROA:-26.00%
PB:-5.96
PE(LYR):-20.24

Loading ...

BridgeBio Pharma Inc - Anvisa Approves Beyonttra (Acoramidis) for Attr-Cm in Brazil on May 4, 2026

THOMSON REUTERS
·
May 08

BridgeBio Pharma Q1 EPS USD -0.84

THOMSON REUTERS
·
May 08

BridgeBio Pharma Inc - Authorizes Share Repurchase Program of up to $500 Mln

THOMSON REUTERS
·
May 08

BridgeBio Pharma Inc - Q1 Total Revenues $194.5 Mln

THOMSON REUTERS
·
May 08

Calendar of U.S. Earnings Expected in the Week Ahead

Dow Jones
·
May 07

BridgeBio receives regulatory approval in Brazil for Beyonttra

TIPRANKS
·
May 07

BridgeBio participates in BofA Securities Health Care Conference fireside chat

Reuters
·
May 07

Brazil regulator ANVISA approves BridgeBio Beyonttra for ATTR cardiomyopathy treatment

Reuters
·
May 06

Beyonttra™ (Acoramidis), the First Near-Complete Ttr Stabilizer (≥90%), Approved by Anvisa to Treat Attr-Cm in Brazil

THOMSON REUTERS
·
May 06

BridgeBio Oncology Therapeutics Inc expected to post a loss of 53 cents a share - Earnings Preview

Reuters
·
May 06

BridgeBio to present Phase 3 CALIBRATE primary results for encaleret at 2026 ECE

Reuters
·
May 05

BridgeBio CAO Maricel Apuli disposes 2,000 shares worth $143,160

Reuters
·
May 05

BridgeBio presents new Phase 3 acoramidis ATTR-CM outcomes data at ESC-HF 2026

Reuters
·
May 04

Analysts Are Bullish on Top Healthcare Stocks: Amgen (AMGN), BridgeBio Pharma (BBIO)

TIPRANKS
·
May 03

BridgeBio Oncology Therapeutics’ Principal Accounting Officer Marc Cobo files Form 3 ownership statement

Reuters
·
May 01

BridgeBio Oncology Therapeutics COO Idan Elmelech files initial beneficial ownership statement

Reuters
·
May 01

BridgeBio to report first-quarter results, host conference call after market close

Reuters
·
Apr 30

Calendar of U.S. Earnings Expected in the Week Ahead

Dow Jones
·
Apr 30

BridgeBio price target raised to $102 from $95 at Truist

TIPRANKS
·
Apr 29

BridgeBio Pharma Price Target Maintained With a $100.00/Share by HC Wainwright & Co.

Dow Jones
·
Apr 29